Prions: protein aggregation and infectious diseases.

Transmissible spongiform encephalopathies (TSEs) are inevitably lethal neurodegenerative diseases that affect humans and a large variety of animals. The infectious agent responsible for TSEs is the prion, an abnormally folded and aggregated protein that propagates itself by imposing its conformation onto the cellular prion protein (PrPC) of the host. PrPC is necessary for prion replication and for prion-induced neurodegeneration, yet the proximal causes of neuronal injury and death are still poorly understood. Prion toxicity may arise from the interference with the normal function of PrPC, and therefore, understanding the physiological role of PrPC may help to clarify the mechanism underlying prion diseases. Here we discuss the evolution of the prion concept and how prion-like mechanisms may apply to other protein aggregation diseases. We describe the clinical and the pathological features of the prion diseases in human and animals, the events occurring during neuroinvasion, and the possible scenarios underlying brain damage. Finally, we discuss potential antiprion therapies and current developments in the realm of prion diagnostics.

[1]  F. Heppner,et al.  Pathogenesis of prion diseases: possible implications of microglial cells. , 2001, Progress in brain research.

[2]  J. Gerstmann,et al.  Über eine eigenartige hereditär- familiäre Erkrankung des Zentralnervensystems , 1935 .

[3]  A. Aguzzi,et al.  Normal host prion protein necessary for scrapie-induced neurotoxicity , 1996, Nature.

[4]  G. Dell’Omo,et al.  Efficient Transmission and Characterization of Creutzfeldt–Jakob Disease Strains in Bank Voles , 2006, PLoS pathogens.

[5]  E. Kandel,et al.  A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties , 2003, Cell.

[6]  T. Wisniewski,et al.  Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides , 2000, The Lancet.

[7]  Edrun A. Schnell,et al.  Conjugated Polyelectrolytes—Conformation‐Sensitive Optical Probes for Staining and Characterization of Amyloid Deposits , 2006, Chembiochem : a European journal of chemical biology.

[8]  O. Andréoletti,et al.  Prions in Milk from Ewes Incubating Natural Scrapie , 2008, PLoS pathogens.

[9]  J. Zajicek,et al.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease , 1998, The Lancet.

[10]  J. Cooper.  Actin Dynamics: Tropomyosin Provides Stability , 2002, Current Biology.

[11]  James R. Harris,et al.  Electron Microscopy of Proteins , 1982 .

[12]  N. Hunter,et al.  Distribution of the prion protein in sheep terminally affected with BSE following experimental oral transmission. , 2001, The Journal of general virology.

[13]  A. Aguzzi,et al.  Spongiform encephalopathies: a suspicious signature. , 1996, Nature.

[14]  G. J. Raymond,et al.  Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin , 2003, Journal of Virology.

[15]  A. Aguzzi,et al.  Antiprion immunotherapy: to suppress or to stimulate? , 2004, Nature Reviews Immunology.

[16]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[17]  A. Aguzzi,et al.  Prion protein (PrP) with amino‐proximal deletions restoring susceptibility of PrP knockout mice to scrapie. , 1996, The EMBO journal.

[18]  J. Collinge,et al.  Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin , 2008, The Biochemical journal.

[19]  R. Petersen,et al.  Fatal Familial Insomnia and Familial Creutzfeldt‐Jakob Disease: Clinical, Pathological and Molecular Features , 1995, Brain pathology.

[20]  A. Aguzzi,et al.  Scrapie Pathogenesis in Subclinically Infected B-Cell-Deficient Mice , 1999, Journal of Virology.

[21]  S. Prusiner.  Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[22]  S. Thobois,et al.  Quinacrine‐induced cytolytic hepatitis in sporadic Creutzfeldt–Jakob disease , 2003, Annals of neurology.

[23]  John Collinge,et al.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease , 1991, Nature.

[24]  L. Hood,et al.  Asparagine-linked glycosylation of the scrapie and cellular prion proteins. , 1989, Archives of biochemistry and biophysics.

[25]  A. Aguzzi,et al.  High Prion and PrPSc Levels but Delayed Onset of Disease in Scrapie-Inoculated Mice Heterozygous for a Disrupted PrP Gene , 1994, Molecular medicine.

[26]  A. Aguzzi.  Unraveling prion strains with cell biology and organic chemistry , 2008, Proceedings of the National Academy of Sciences.

[27]  S. Lindquist,et al.  Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Hauw,et al.  The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease , 2003, Nature Medicine.

[29]  S. Hornemann,et al.  Prion strain discrimination using luminescent conjugated polymers , 2007, Nature Methods.

[30]  J. Collinge,et al.  Targeting Cellular Prion Protein Reverses Early Cognitive Deficits and Neurophysiological Dysfunction in Prion-Infected Mice , 2007, Neuron.

[31]  B. Chesebro,et al.  Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain , 1985, Nature.

[32]  T. Wisniewski,et al.  Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. , 2001, The Journal of clinical investigation.

[33]  S. Prusiner,et al.  Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. , 1980, Biochemistry.

[34]  P. McBride,et al.  Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie , 1989, Neuroscience Letters.

[35]  H. Naiki,et al.  Ultrasonication-induced Amyloid Fibril Formation of β2-Microglobulin* , 2005, Journal of Biological Chemistry.

[36]  T. Mohandas,et al.  Assignment of the human and mouse prion protein genes to homologous chromosomes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Hutter,et al.  No Superoxide Dismutase Activity of Cellular Prion Protein in vivo , 2003, Biological chemistry.

[38]  K. Kato,et al.  High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[39]  J. Gommerman,et al.  Lymphotoxin/LIGHT, lymphoid microenvironments and autoimmune disease , 2003, Nature Reviews Immunology.

[40]  M. Fisman.  Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. , 1986, The New England journal of medicine.

[41]  J. Castilla,et al.  Accelerated High Fidelity Prion Amplification Within and Across Prion Species Barriers , 2008, PLoS pathogens.

[42]  P. Roller,et al.  Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. , 1993, The Journal of biological chemistry.

[43]  G. Byrne,et al.  Glycosyl Phosphatidylinositol Anchor , 1998, Nephron Experimental Nephrology.

[44]  B. Volpe,et al.  Cross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo , 2004, Science.

[45]  L. Hood,et al.  Genomic structure of the human prion protein gene. , 1991, American journal of human genetics.

[46]  F. Heppner,et al.  Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes. , 2003, The American journal of pathology.

[47]  S. Supattapone,et al.  Formation of native prions from minimal components in vitro , 2007, Proceedings of the National Academy of Sciences.

[48]  P. Kane,et al.  Protein splicing converts the yeast TFP1 gene product to the 69-kD subunit of the vacuolar H(+)-adenosine triphosphatase. , 1990, Science.

[49]  J. Manson,et al.  Host PrP Glycosylation: A Major Factor Determining the Outcome of Prion Infection , 2008, PLoS biology.

[50]  H. Fraser,et al.  Transmission of bovine spongiform encephalopathy to mice , 1988, Veterinary Record.

[51]  G. J. Raymond,et al.  Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells , 1993, Journal of virology.

[52]  J. Ernst,et al.  Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis. , 2007, The Journal of clinical investigation.

[53]  A. Aguzzi,et al.  Mammalian Prion Biology One Century of Evolving Concepts , 2004, Cell.

[54]  S. Prusiner,et al.  Measurement of the scrapie agent using an incubation time interval assay , 1982, Annals of neurology.

[55]  E. Opie.  THE RELATION OE DIABETES MELLITUS TO LESIONS OF THE PANCREAS. HYALINE DEGENERATION OF THE ISLANDS OE LANGERHANS , 1901, The Journal of experimental medicine.

[56]  H. Kretzschmar,et al.  Prion Protein-Deficient Cells Show Altered Response to Oxidative Stress Due to Decreased SOD-1 Activity , 1997, Experimental Neurology.

[57]  A. Ghani,et al.  Assessment of the prevalence of vCJD through testing tonsils and appendices for abnormal prion protein , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[58]  R. Hegde,et al.  Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration. , 2008, Developmental cell.

[59]  Richard M. Page,et al.  Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease , 2005, Neuroscience.

[60]  A. Aguzzi,et al.  Human prion diseases: epidemiology and integrated risk assessment , 2003, The Lancet Neurology.

[61]  S. Prusiner,et al.  Regional mapping of prion proteins in brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[62]  S. Prusiner,et al.  Amyloid plaques in Creutzfeldt‐Jakob disease stain with prion protein antibodies , 1986, Annals of neurology.

[63]  F. Cohen,et al.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes , 2006, Proceedings of the National Academy of Sciences.

[64]  K. Roth,et al.  Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125 , 2007, The EMBO journal.

[65]  K. Madden,et al.  Noradrenergic sympathetic innervation of lymphoid organs. , 1988, Progress in allergy.

[66]  S. Prusiner,et al.  Determination of scrapie agent titer from incubation period measurements in hamsters. , 1981, Advances in experimental medicine and biology.

[67]  D. Gajdusek.  Unconventional viruses and the origin and disappearance of kuru. , 1977, Science.

[68]  T. Alper,et al.  The scrapie agent: evidence against its dependence for replication on intrinsic nucleic acid. , 1978, The Journal of general virology.

[69]  K. Sletten,et al.  Fibril in senile systemic amyloidosis is derived from normal transthyretin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[70]  F. Cohen,et al.  Prion diseases of humans and animals , 1996 .

[71]  T. Crow,et al.  Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. , 1993, International journal of experimental pathology.

[72]  C. Locht,et al.  Immune system-dependent and -independent replication of the scrapie agent , 1996, Journal of virology.

[73]  A. Aguzzi,et al.  Creutzfeldt–Jakob disease and inclusion body myositis: Abundant disease‐associated prion protein in muscle , 2004, Annals of neurology.

[74]  A. Aguzzi,et al.  A suspicious signature , 1996, Nature.

[75]  A. Aguzzi.  Neuro-immune connection in spread of prions in the body? , 1997, The Lancet.

[76]  Michael P H Stumpf,et al.  Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics , 2003, Science.

[77]  J. Collinge,et al.  Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease , 2008, Proceedings of the National Academy of Sciences.

[78]  J. Castilla,et al.  Crossing the Species Barrier by PrPSc Replication In Vitro Generates Unique Infectious Prions , 2008, Cell.

[79]  J. Castilla,et al.  Detection of prions in blood , 2005, Nature Medicine.

[80]  S. Prusiner,et al.  Purified prion proteins and scrapie infectivity copartition into liposomes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[81]  A. Aguzzi,et al.  Efficient Lymphoreticular Prion Propagation Requires PrPc in Stromal and Hematopoietic Cells , 2001, Journal of Virology.

[82]  J. Ridet,et al.  alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[83]  S. Prusiner,et al.  Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.

[84]  G. C. Millson,et al.  Further observations on the experimental production of scrapie in goats and sheep. , 1960, Journal of comparative pathology.

[85]  J. Griffith,et al.  Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.

[86]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[87]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[88]  G. D. Hunter,et al.  An experimental examination of the scrapie agent in cell membrane mixtures. II. The association of scrapie activity with membrane fractions. , 1971, Journal of comparative pathology.

[89]  K. Rajewsky,et al.  Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin β Receptor by Radioresistant Stromal Cells and of Lymphotoxin β and Tumor Necrosis Factor by B Cells , 1999, The Journal of experimental medicine.

[90]  H. Kretzschmar,et al.  Early Spread of Scrapie from the Gastrointestinal Tract to the Central Nervous System Involves Autonomic Fibers of the Splanchnic and Vagus Nerves , 2001, Journal of Virology.

[91]  C. Sigurdson,et al.  A prion disease of cervids: chronic wasting disease. , 2008, Veterinary research.

[92]  K. Madden,et al.  Noradrenergic Sympathetic Innervation of Lymphoid Organs1 , 1988 .

[93]  Pauline M. Rudd,et al.  Antibodies inhibit prion propagation and clear cell cultures of prion infectivity , 2001, Nature.

[94]  B. Caughey,et al.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease‐resistant state , 1999, The EMBO journal.

[95]  A. Aguzzi,et al.  Prions, cytokines, and chemokines: a meeting in lymphoid organs. , 2005, Immunity.

[96]  A. Aguzzi,et al.  Lethal recessive myelin toxicity of prion protein lacking its central domain , 2007, The EMBO journal.

[97]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[98]  R. Riek,et al.  Prion (PrPSc)-specific epitope defined by a monoclonal antibody , 1997, Nature.

[99]  G. Wells,et al.  Primary parenteral transmission of bovine spongiform encephalopathy to the pig , 1990, Veterinary Record.

[100]  F. Cohen,et al.  Prion Protein of 106 Residues Creates an Artificial Transmission Barrier for Prion Replication in Transgenic Mice , 1999, Cell.

[101]  G. Keller,et al.  Endocytosis of glycophospholipid‐anchored and transmembrane forms of CD4 by different endocytic pathways. , 1992, The EMBO journal.

[102]  M. Jeffrey,et al.  Correlative light and electron microscopy studies of PrP localisation in 87V scrapie , 1994, Brain Research.

[103]  A. Weinzierl,et al.  Alteration of NF-κB activity leads to mitochondrial apoptosis after infection with pathological prion protein , 2007, Cellular microbiology.

[104]  J. Collinge,et al.  Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. , 2006, Brain : a journal of neurology.

[105]  L. Lannfelt,et al.  Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes. , 2007, ACS chemical biology.

[106]  F. Cohen,et al.  Branched Polyamines Cure Prion-Infected Neuroblastoma Cells , 2001, Journal of Virology.

[107]  F. Heppner,et al.  Spongiform encephalopathies: insights from transgenic models. , 2001, Advances in virus research.

[108]  C. Weissmann.  The prion's progress , 1991, Nature.

[109]  Roger Cooke,et al.  Conformational variations in an infectious protein determine prion strain differences , 2004, Nature.

[110]  A. Aguzzi,et al.  Insights into prion strains and neurotoxicity , 2007, Nature Reviews Molecular Cell Biology.

[111]  A. Aguzzi,et al.  PrPSc in mammary glands of sheep affected by scrapie and mastitis , 2005, Nature Medicine.

[112]  A. Aguzzi,et al.  PrP's Double Causes Trouble , 1999, Science.

[113]  K. Hess,et al.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease , 2006, Neurology.

[114]  Ç. Şekercioğlu.  Prion Diseases and a Penchant for Brains , 2004, Science.

[115]  D. Westaway,et al.  The cellular prion protein binds copper in vivo , 1997, Nature.

[116]  D. R. Wilson,et al.  Studies in scrapie. , 1950, Journal of comparative pathology.

[117]  C. Sigurdson,et al.  Prions in Skeletal Muscles of Deer with Chronic Wasting Disease , 2006, Science.

[118]  D. Gajdusek,et al.  DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY , 1977, The Lancet.

[119]  Outram Gw,et al.  Genetic aspects of unconventional virus infections: the basis of the virino hypothesis. , 1988 .

[120]  K. Nilsson,et al.  Conjugated polyelectrolytes: conformation-sensitive optical probes for detection of amyloid fibril formation. , 2005, Biochemistry.

[121]  A. Aguzzi,et al.  Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. , 2003, The New England journal of medicine.

[122]  S. Hornemann,et al.  Strain Fidelity of Chronic Wasting Disease upon Murine Adaptation , 2006, Journal of Virology.

[123]  R. Riek,et al.  Prion protein structural features indicate possible relations to signal peptidases , 1998, FEBS letters.

[124]  P. Lenz,et al.  Activation by prion peptide PrP106–126 induces a NF‐κB‐driven proinflammatory response in human monocyte‐derived dendritic cells , 2003, Journal of leukocyte biology.

[125]  I. Mcconnell,et al.  PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[126]  A. Aguzzi,et al.  Identification of the End Stage of Scrapie Using Infected Neural Grafts , 1998, Brain pathology.

[127]  A. Aguzzi,et al.  Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8 , 2008, The Journal of experimental medicine.

[128]  R. Carp.  TRANSMISSION OF SCRAPIE BY ORAL ROUTE EFFECT OF GINGIVAL SCARIFICATION , 1982, The Lancet.

[129]  G. C. Millson,et al.  Distribution of the scrapie agent in the tissues of experimentally inoculated goats. , 1962, Journal of comparative pathology.

[130]  F. Cohen,et al.  Doppel is an N-glycosylated, glycosylphosphatidylinositol-anchored protein. Expression in testis and ectopic production in the brains of Prnp(0/0) mice predisposed to Purkinje cell loss. , 2000, The Journal of biological chemistry.

[131]  P. Brown,et al.  Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease , 1994, Annals of neurology.

[132]  T. Crow,et al.  CNS amyloid proteins in neurodegenerative diseases , 1988, Neurology.

[133]  L. Bolis,et al.  Molecular cloning of the cDNA coding for Xenopus laevis prion protein , 2001, FEBS letters.

[134]  Jonathan S. Weissman,et al.  The structural basis of yeast prion strain variants , 2007, Nature.

[135]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[136]  F. Heppner,et al.  Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion , 2003, Nature.

[137]  S. Prusiner,et al.  A mouse prion protein transgene rescues mice deficient for the prion protein gene from purkinje cell degeneration and demyelination. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[138]  E. J. Field.  The scrapie agent. , 1967, Lancet.

[139]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[140]  J. Collinge,et al.  Disease-related Prion Protein Forms Aggresomes in Neuronal Cells Leading to Caspase Activation and Apoptosis* , 2005, Journal of Biological Chemistry.

[141]  W. Kerr,et al.  Follicular dendritic cell (FDC) precursors in primary lymphoid tissues. , 1998, Journal of immunology.

[142]  A. LeBlanc,et al.  Prion Protein Protects Human Neurons against Bax-mediated Apoptosis* , 2001, The Journal of Biological Chemistry.

[143]  Christian von Mering,et al.  Expression of Amino-Terminally Truncated PrP in the Mouse Leading to Ataxia and Specific Cerebellar Lesions , 1998, Cell.

[144]  Gary Lynch,et al.  Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice , 1999, Brain Research.

[145]  F. Heppner,et al.  Sympathetic Innervation of Lymphoreticular Organs Is Rate Limiting for Prion Neuroinvasion , 2001, Neuron.

[146]  B. Hjelle,et al.  Hantavirus infection in the Four Corners region of USA in 1998 , 1998, The Lancet.

[147]  A. Aguzzi,et al.  The Comprehensive Native Interactome of a Fully Functional Tagged Prion Protein , 2009, PloS one.

[148]  D. Adams.  The nature of the scrapie agent. , 1986, Medical hypotheses.

[149]  H. Wiśniewski,et al.  Scrapie-associated fibrils in Creutzfeldt–Jakob disease , 1983, Nature.

[150]  J. Collinge,et al.  Human Prion Protein with Valine 129 Prevents Expression of Variant CJD Phenotype , 2004, Science.

[151]  A. Aguzzi,et al.  Antiprion prophylaxis by gene transfer of a soluble prion antagonist. , 2008, The American journal of pathology.

[152]  N. Mabbott,et al.  Role of the GALT in Scrapie Agent Neuroinvasion from the Intestine1 , 2007, The Journal of Immunology.

[153]  A. Aguzzi,et al.  Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain , 2001, The EMBO journal.

[154]  S. Prusiner,et al.  Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes , 1993, Cell.

[155]  DavidJ. Evans,et al.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy , 1997, The Lancet.

[156]  R. S. Stewart,et al.  Cytosolic Prion Protein (PrP) Is Not Toxic in N2a Cells and Primary Neurons Expressing Pathogenic PrP Mutations* , 2005, Journal of Biological Chemistry.

[157]  E. Rivera-Milla,et al.  An evolutionary basis for scrapie disease: identification of a fish prion mRNA. , 2003, Trends in genetics : TIG.

[158]  David G. Russell,et al.  Who puts the tubercle in tuberculosis? , 2007, Nature Reviews Microbiology.

[159]  B. Caughey,et al.  Potent Antiscrapie Activities of Degenerate Phosphorothioate Oligonucleotides , 2006, Antimicrobial Agents and Chemotherapy.

[160]  M. Beekes,et al.  Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. , 1998, The Journal of general virology.

[161]  J. Stamp,et al.  Scrapie disease of sheep. , 1961, World neurology.

[162]  J. Castilla,et al.  In Vitro Generation of Infectious Scrapie Prions , 2005, Cell.

[163]  D. Braunholtz,et al.  Quinacrine in possible or probable CJD , 2002, BMJ : British Medical Journal.

[164]  R. Will,et al.  Diagnosing Creutzfeldt-Jakob disease , 1996, BMJ.

[165]  F. Cohen,et al.  A Protease-Resistant 61-Residue Prion Peptide Causes Neurodegeneration in Transgenic Mice , 2001, Molecular and Cellular Biology.

[166]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[167]  P. Achermann,et al.  Altered circadian activity rhythms and sleep in mice devoid of prion protein , 1996, Nature.

[168]  N. Mabbott,et al.  Prions and their lethal journey to the brain , 2006, Nature Reviews Microbiology.

[169]  S. Mead,et al.  Prion disease genetics , 2006, European Journal of Human Genetics.

[170]  S. Lindquist,et al.  Conversion of PrP to a Self-Perpetuating PrPSc-like Conformation in the Cytosol , 2002, Science.

[171]  K. Hess,et al.  A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001–2004 , 2009, BMC public health.

[172]  A. Aguzzi,et al.  The prion organotypic slice culture assay—POSCA , 2008, Nature Protocols.

[173]  S. Prusiner,et al.  Evidence for synthesis of scrapie prion proteins in the endocytic pathway. , 1992, The Journal of biological chemistry.

[174]  D. Cleveland,et al.  Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond , 2009, The Journal of cell biology.

[175]  B. Ghetti,et al.  Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody , 2006, Neurobiology of Disease.

[176]  R. Marsh,et al.  Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology, and pathogenesis. , 1975, The Journal of infectious diseases.

[177]  John Q. Trojanowski,et al.  Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.

[178]  D. Taylor,et al.  Scrapie infection can be established readily through skin scarification in immunocompetent but not immunodeficient mice. , 1996, The Journal of general virology.

[179]  Kurt Wüthrich,et al.  Prion protein NMR structures of chickens, turtles, and frogs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[180]  R. Flavell,et al.  Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. , 1997, Immunity.

[181]  C. Masters,et al.  Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. , 1978, Brain : a journal of neurology.

[182]  Ann-Shyn Chiang,et al.  Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for Alzheimer's disease , 2004 .

[183]  J. P. M'gowan.  Investigation into the Disease of Sheep called " Scrapie " (Traberkrankheit; La Tremblante) with Especial Reference to its Association with Sarcosporidiosis. With an Appendix on a Case of Johne's Disease in the Sheep. , 1914 .

[184]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[185]  P. Castaigne,et al.  The epidemiology of Creutzfeldt‐Jakob disease , 1987, Neurology.

[186]  G. J. Raymond,et al.  Assays of protease-resistant prion protein and its formation. , 1999, Methods in enzymology.

[187]  G. J. Raymond,et al.  The most infectious prion protein particles , 2005, Nature.

[188]  Stephen J. DeArmond,et al.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.

[189]  G. Friedlander,et al.  Characterization of Detergent-insoluble Complexes Containing the Cellular Prion Protein and Its Scrapie Isoform* , 1997, The Journal of Biological Chemistry.

[190]  C. Locht,et al.  Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[191]  S. Ratté,et al.  Post‐natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration , 2002, The EMBO journal.

[192]  B. Becher,et al.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.

[193]  A. Aguzzi,et al.  B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[194]  C. Vnencak-Jones,et al.  Identification of heterogeneous PrP gene deletions in controls by detection of allele-specific heteroduplexes (DASH) , 1992, American journal of human genetics.

[195]  P. Sarradin,et al.  Cases of scrapie with unusual features in Norway and designation of a new type, Nor98 , 2003, Veterinary Record.

[196]  M. Karin.  Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[197]  A. Aguzzi,et al.  Soluble Dimeric Prion Protein Binds PrPSc In Vivo and Antagonizes Prion Disease , 2003, Cell.

[198]  E. Wolf,et al.  A Putative Chemokine Receptor, BLR1, Directs B Cell Migration to Defined Lymphoid Organs and Specific Anatomic Compartments of the Spleen , 1996, Cell.

[199]  K. Rajewsky,et al.  Critical role for β7 integrins in formation of the gut-associated lymphoid tissue , 1996, Nature.

[200]  J. Castilla,et al.  Ultra-efficient Replication of Infectious Prions by Automated Protein Misfolding Cyclic Amplification* , 2006, Journal of Biological Chemistry.

[201]  S. Prusiner,et al.  Distinct prion proteins in short and long scrapie incubation period mice , 1987, Cell.

[202]  F. Meggendorfer.  Klinische und genealogische Beobachtungen bei einem Fall von spastischer Pseudosklerose Jakobs , 1930 .

[203]  J Mackenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[204]  A. Aguzzi,et al.  The shifting biology of prions , 2001, Brain Research Reviews.

[205]  S. Prusiner,et al.  A protease-resistant protein is a structural component of the Scrapie prion , 1983, Cell.

[206]  Endoplasmic reticulum stress, PrP trafficking, and neurodegeneration. , 2008, Developmental cell.

[207]  H. Kretzschmar,et al.  Postexposure prophylaxis against prion disease with a stimulator of innate immunity , 2002, The Lancet.

[208]  A. Andrés,et al.  The prion protein gene in humans revisited: lessons from a worldwide resequencing study. , 2005, Genome research.

[209]  M. Sousa,et al.  Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. , 2001, The American journal of pathology.

[210]  Claudio Soto,et al.  Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. , 2006, Trends in biochemical sciences.

[211]  A. Aguzzi.  Prions and the immune system: a journey through gut, spleen, and nerves. , 2003, Advances in immunology.

[212]  F. Heppner,et al.  Immune system and peripheral nerves in propagation of prions to CNS. , 2003, British medical bulletin.

[213]  J. Castilla,et al.  Pre‐symptomatic detection of prions by cyclic amplification of protein misfolding , 2005, FEBS letters.

[214]  Christian Haass,et al.  Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease , 2003, Science.

[215]  J. Trojanowski,et al.  Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. , 2002, Science.

[216]  S. Prusiner,et al.  Paradoxical shortening of scrapie incubation times by expression of prion protein transgenes derived from long incubation period mice , 1991, Neuron.

[217]  A. Darinskas,et al.  Does the Cytotoxic Effect of Transient Amyloid Oligomers from Common Equine Lysozyme in Vitro Imply Innate Amyloid Toxicity?* , 2005, Journal of Biological Chemistry.

[218]  D. Hilton.  Pathogenesis and prevalence of variant Creutzfeldt–Jakob disease , 2006, The Journal of pathology.

[219]  H. Fraser,et al.  Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells , 1999, Nature Medicine.

[220]  A. Aguzzi,et al.  Normal neurogenesis and scrapie pathogenesis in neural grafts lacking the prion protein homologue Doppel , 2001, EMBO reports.

[221]  N. Gonatas,et al.  Creutzfeldt‐Jakob disease in a 20‐year‐old woman , 1980, Neurology.

[222]  M. Palmer,et al.  Prion protein is necessary for normal synaptic function , 1994, Nature.

[223]  Sebastian Brandner,et al.  Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis , 2003, Science.

[224]  F. Heppner,et al.  Absence of the prion protein homologue Doppel causes male sterility , 2002, The EMBO journal.

[225]  B. Becher,et al.  Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[226]  Mechanism of scrapie replication. , 1994, Science.

[227]  A. Aguzzi,et al.  Prions and peripheral nerves: A deadly rendezvous , 2007, Journal of neuroscience research.

[228]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[229]  S. Liao,et al.  Lymphoid organ development: from ontogeny to neogenesis , 2006, Nature Immunology.

[230]  R. Anderson,et al.  Estimation of the number of people incubating variant CJD , 1998, The Lancet.

[231]  F. V. van Landeghem,et al.  Rapid disease development in scrapie‐infected mice deficient for CD40 ligand , 2004, EMBO reports.

[232]  I. Pattison,et al.  The possible nature of the transmissible agent of scrapie , 1967, Veterinary Record.

[233]  V. Daggett,et al.  PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. , 1999, Journal of neuropathology and experimental neurology.

[234]  M. Clarke,et al.  Infection of a cell line of mouse L fibroblasts with scrapie agent , 1976, Nature.

[235]  P. Aebischer,et al.  α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[236]  J. Ironside,et al.  Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. , 2006, The American journal of pathology.

[237]  A. Aguzzi,et al.  PrP‐dependent association of prions with splenic but not circulating lymphocytes of scrapie‐infected mice , 1999, EMBO Journal.

[238]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[239]  T. Crow,et al.  Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. , 1994, Molecular neurobiology.

[240]  W. Caughey,et al.  Porphyrin and phthalocyanine antiscrapie compounds. , 2000, Science.

[241]  Prion biology: the quest for the test , 2007, Nature Methods.

[242]  Ann-Shyn Chiang,et al.  Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[243]  S. Prusiner,et al.  Antibodies to a scrapie prion protein , 1984, Nature.

[244]  G. Multhaup,et al.  Fibrils from brains of cows with new cattle disease contain scrapie-associated protein , 1988, Nature.

[245]  Tong Liu,et al.  Heterogeneity of normal prion protein in two‐dimensional immunoblot: presence of various glycosylated and truncated forms , 2002, Journal of neurochemistry.

[246]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[247]  Beat H. Meier,et al.  Amyloid Fibrils of the HET-s(218–289) Prion Form a β Solenoid with a Triangular Hydrophobic Core , 2008, Science.

[248]  C. Cunningham,et al.  Atypical inflammation in the central nervous system in prion disease , 2002, Current opinion in neurology.

[249]  F. Mackay,et al.  Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie , 2000, Nature Medicine.

[250]  J. Collinge,et al.  Monoclonal antibodies inhibit prion replication and delay the development of prion disease , 2003, Nature.

[251]  R. Kimberlin,et al.  Pathogenesis of scrapie in mice after intragastric infection. , 1989, Virus research.

[252]  D. Gajdusek,et al.  Kuru; clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of New Guinea. , 1959, The American journal of medicine.

[253]  R. Riek,et al.  Recombinant full‐length murine prion protein, mPrP(23–231): purification and spectroscopic characterization , 1997, FEBS letters.

[254]  S. Prusiner,et al.  Identification of a protein that purifies with the scrapie prion. , 1982, Science.

[255]  H. Fraser,et al.  Conjunctival instillation of scrapie in mice can produce disease. , 1993, Veterinary microbiology.

[256]  Michael W. Miller,et al.  Prion disease: Horizontal prion transmission in mule deer , 2003, Nature.

[257]  D. Riesner.  Transmissible spongiform encephalopathies: the prion theory--background and basic information. , 2004, Contributions to microbiology.

[258]  B. Caughey,et al.  Lysosomotropic Agents and Cysteine Protease Inhibitors Inhibit Scrapie-Associated Prion Protein Accumulation , 2000, Journal of virology.

[259]  A. Aguzzi,et al.  Small is not beautiful: antagonizing functions for the prion protein PrPC and its homologue Dpl , 2002, Trends in Neurosciences.

[260]  Robert J Warren,et al.  Infectious Prions in the Saliva and Blood of Deer with Chronic Wasting Disease , 2006, Science.

[261]  Adriano Aguzzi,et al.  Pathogenesis of prion diseases: current status and future outlook , 2006, Nature Reviews Microbiology.

[262]  M. Walport,et al.  Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie , 2001, Nature Medicine.

[263]  N. Mabbott,et al.  Role of the draining lymph node in scrapie agent transmission from the skin. , 2007, Immunology letters.

[264]  B. Aronow,et al.  Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers , 2004 .

[265]  N. Mabbott,et al.  Migrating intestinal dendritic cells transport PrP(Sc) from the gut. , 2002, The Journal of general virology.

[266]  A. Aguzzi,et al.  Olfactory behavior and physiology are disrupted in prion protein knockout mice , 2008, Nature Neuroscience.

[267]  R. Flavell,et al.  Distinct Roles in Lymphoid Organogenesis for Lymphotoxins α and β Revealed in Lymphotoxin β–Deficient Mice , 1997 .

[268]  F. Kametani,et al.  Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease , 2008, Proceedings of the National Academy of Sciences.

[269]  K. Ikuta,et al.  Experimental Transmission of Abnormal Prion Protein (PrPsc) in the Small Intestinal Epithelial Cells of Neonatal Mice , 2003, Veterinary pathology.

[270]  W. Kirschbaum.  Zwei eigenartige Erkrankungen des Zentralnervensystems nach Art der spastischen Pseudosklerose (Jakob) , 1924 .

[271]  S. Prusiner,et al.  Amyloid protein of Gerstmann‐Sträussler‐Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N‐terminal glycine at codon 58. , 1991, EMBO Journal.

[272]  H. Fraser.  Neuronal spread of scrapie agent and targeting of lesions within the retino-tectal pathway , 1982, Nature.

[273]  B. Becher,et al.  Germinal center B cells are dispensable in prion transport and neuroinvasion , 2007, Journal of Neuroimmunology.

[274]  M. Bruce,et al.  Scrapie strain variation and mutation. , 1993, British medical bulletin.

[275]  J. Griffith,et al.  Self-replication and scrapie. , 1967, Nature.

[276]  Veerle Baekelandt,et al.  Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.

[277]  N. Kanu,et al.  Transfer of Scrapie Prion Infectivity by Cell Contact in Culture , 2002, Current Biology.

[278]  A. Aguzzi,et al.  PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain , 1997, Nature.

[279]  M. Gasset,et al.  Methionine sulfoxides on PrPSc: a prion-specific covalent signature. , 2008, Biochemistry.

[280]  S. Akira,et al.  Prion pathogenesis in the absence of Toll‐like receptor signalling , 2003, EMBO reports.

[281]  John Collinge,et al.  Kuru in the 21st century—an acquired human prion disease with very long incubation periods , 2006, The Lancet.

[282]  D. Harris,et al.  Glycolipid-anchored proteins in neuroblastoma cells form detergent- resistant complexes without caveolin , 1995, The Journal of cell biology.

[283]  S. Prusiner,et al.  Glycosylation differences between the normal and pathogenic prion protein isoforms. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[284]  M. Sy,et al.  Intercellular Transfer of the Cellular Prion Protein* , 2002, The Journal of Biological Chemistry.

[285]  A. Aguzzi,et al.  Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. , 2000, Science.

[286]  A. Aguzzi,et al.  No propagation of prions in mice devoid of PrP , 1994, Cell.

[287]  M. Palmer,et al.  Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease , 1991, The Lancet.

[288]  D. Gajdusek,et al.  Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. , 1957, The New England journal of medicine.

[289]  W. Faigle,et al.  Cells release prions in association with exosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[290]  H. Fraser,et al.  The sequential development of the brain lesion of scrapie in three strains of mice. , 1968, Journal of comparative pathology.

[291]  M. Diamond,et al.  Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.

[292]  S. Prusiner,et al.  A Change in the Conformation of Prions Accompanies the Emergence of a New Prion Strain , 2002, Neuron.

[293]  R. L. Chandler.  Encephalopathy in mice produced by inoculation with scrapie brain material. , 1961, Lancet.

[294]  U. Baxa,et al.  Prion generation in vitro: amyloid of Ure2p is infectious , 2005, The EMBO journal.

[295]  S. Prusiner,et al.  Scrapie agent contains a hydrophobic protein. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[296]  G. J. Raymond,et al.  Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease , 2000, The EMBO journal.

[297]  R. Fletterick,et al.  Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[298]  N. Thompson Hobbs,et al.  Environmental Sources of Prion Transmission in Mule Deer , 2004, Emerging infectious diseases.

[299]  Suvankar Pal,et al.  Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report , 2006, The Lancet.

[300]  A. Aguzzi,et al.  PrP expression in B lymphocytes is not required for prion neuroinvasion , 1998, Nature Medicine.

[301]  A. Aguzzi,et al.  PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion. , 2000, The Journal of general virology.

[302]  A. Dickinson,et al.  Genetic aspects of unconventional virus infections: the basis of the virino hypothesis. , 1988, Ciba Foundation symposium.

[303]  N. Mabbott,et al.  In Vivo Depletion of CD11c+ Cells Impairs Scrapie Agent Neuroinvasion from the Intestine1 , 2007, The Journal of Immunology.

[304]  Mark Head,et al.  Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .

[305]  A. Aguzzi.  Understanding the diversity of prions , 2004, Nature Cell Biology.

[306]  C. Farrington,et al.  Deaths from variant Creutzfeldt-Jakob disease in the UK , 2003, The Lancet.

[307]  M. Braunfeld,et al.  Identification of prion amyloid filaments in scrapie-infected brain , 1985, Cell.

[308]  Stephen J. DeArmond,et al.  Transmission of Elk and Deer Prions to Transgenic Mice , 2006, Journal of Virology.

[309]  Inyoul Y. Lee,et al.  Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. , 1999, Journal of molecular biology.

[310]  J Collinge,et al.  Molecular neurology of prion disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[311]  F. Mackay,et al.  Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice , 1997, European journal of immunology.

[312]  J. Collinge,et al.  Disease-associated prion protein oligomers inhibit the 26S proteasome. , 2007, Molecular cell.

[313]  A. Dickinson,et al.  Biological evidence that scrapie agent has an independent genome. , 1987, The Journal of general virology.

[314]  Jurg Ott,et al.  Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome , 1989, Nature.

[315]  C. Dobson.  Protein folding and misfolding , 2003, Nature.

[316]  P. Righetti,et al.  Searching for markers of Creutzfeldt‐Jakob disease in cerebrospinal fluid by two‐dimensional mapping , 2006, Proteomics.

[317]  J. Collinge,et al.  Regional heterogeneity of cellular prion protein isoforms in the mouse brain. , 2003, Brain : a journal of neurology.

[318]  S. Prusiner,et al.  Transmissible and genetic prion diseases share a common pathway of neurodegeneration , 1999, Nature.

[319]  K Wüthrich,et al.  NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.

[320]  G. Forloni,et al.  Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. , 1997, Science.

[321]  J. Ryan,et al.  Bovine spongiform encephalopathy: epidemiological features 1985 to 1990 , 1992, Veterinary Record.

[322]  S. Prusiner.  CREUTZFELDT‐JAKOB DISEASE AND SCRAPIE PRIONS , 1989, Alzheimer disease and associated disorders.

[323]  J. Kraehenbuhl,et al.  Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. , 1997, Science.

[324]  M. Michelitsch,et al.  Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC , 2007, Proceedings of the National Academy of Sciences.

[325]  C. Weissmann,et al.  A 'unified theory' of prion propagation , 1991, Nature.

[326]  S. Hornemann,et al.  De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis , 2009, Proceedings of the National Academy of Sciences.

[327]  W. S. Gordon.  Advances in veterinary research. , 1946, The Veterinary record.

[328]  A. Aguzzi,et al.  Prions: Pathogenesis and Reverse Genetics , 2000, Annals of the New York Academy of Sciences.

[329]  E. Masliah,et al.  Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie , 2005, Science.

[330]  S. Prusiner,et al.  Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis , 1991, Journal of virology.

[331]  Per Westermark,et al.  Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[332]  S. Prusiner,et al.  Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[333]  Jeppe Falsig,et al.  A versatile prion replication assay in organotypic brain slices , 2008, Nature Neuroscience.

[334]  S. Prusiner,et al.  Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene , 1986, Cell.

[335]  J. Tamada,et al.  Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[336]  E. Sigurdsson,et al.  High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice , 2008, Neuroscience.

[337]  H. Wiśniewski,et al.  Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. , 1999, Brain research. Molecular brain research.

[338]  F. Cohen,et al.  Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix , 1997, Nature Medicine.

[339]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[340]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[341]  C. Julius,et al.  Prion strain discrimination in cell culture: The cell panel assay , 2007, Proceedings of the National Academy of Sciences.

[342]  David A Agard,et al.  Structural studies of the scrapie prion protein by electron crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[343]  T. Alper,et al.  The exceptionally small size of the scrapie agent. , 1966, Biochemical and biophysical research communications.

[344]  H. Fraser,et al.  Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. , 1973, Journal of comparative pathology.

[345]  A. Aguzzi,et al.  Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[346]  V. Perry,et al.  EVIDENCE FOR AN EARLY INFLAMMATORY RESPONSE IN THE CENTRAL NERVOUS SYSTEM OF MICE WITH SCRAPIE , 1996, Neuroscience.

[347]  J. Morris,et al.  Scrapie in Mice , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[348]  A. Aguzzi,et al.  Urinary α1-Antichymotrypsin: A Biomarker of Prion Infection , 2008, PloS one.

[349]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[350]  M. Kurrer,et al.  Lymphotoxin-dependent prion replication in inflammatory stromal cells of granulomas. , 2008, Immunity.

[351]  F. Cohen,et al.  Dominant-negative inhibition of prion replication in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[352]  S. Supattapone,et al.  Protease-resistant Prion Protein Amplification Reconstituted with Partially Purified Substrates and Synthetic Polyanions* , 2005, Journal of Biological Chemistry.

[353]  M. Smits,et al.  Preclinical test for prion diseases , 1996, Nature.

[354]  F. Heppner,et al.  Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies , 2001, Science.

[355]  B. Caughey,et al.  Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[356]  L. Munson,et al.  EXTRINSIC FACTORS SIGNIFICANTLY AFFECT PATTERNS OF DISEASE IN FREE-RANGING AND CAPTIVE CHEETAH (ACINONYX JUBATUS) POPULATIONS , 2005, Journal of wildlife diseases.

[357]  K. Wüthrich,et al.  Prion protein NMR structures of cats, dogs, pigs, and sheep. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[358]  M. Dawson,et al.  Preliminary evidence of the experimental transmissibility of bovine spongiform encephalopathy to cattle , 1990, Veterinary Record.

[359]  W. Banks,et al.  Passage of murine scrapie prion protein across the mouse vascular blood-brain barrier. , 2004, Biochemical and biophysical research communications.

[360]  Gordon Ws.  Advances in veterinary research. , 1946 .

[361]  Atanas V Koulov,et al.  Functional amyloid--from bacteria to humans. , 2007, Trends in biochemical sciences.

[362]  Rodrigo Morales,et al.  Cell‐free propagation of prion strains , 2008, The EMBO journal.

[363]  M. Clarke,et al.  Pathogenesis of mouse scrapie: distribution of agent in the pulp and stroma of infected spleens. , 1984, Veterinary microbiology.

[364]  J. Gommerman,et al.  Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. , 2002, The Journal of clinical investigation.

[365]  A. Aguzzi,et al.  Perspectives: neurobiology. PrP's double causes trouble. , 1999, Science.

[366]  F. Cohen,et al.  Synthetic Mammalian Prions , 2004, Science.

[367]  Marsh Rf,et al.  Transmissible mink encephalopathy. , 1992 .

[368]  A. Aguzzi.  Prion diseases, blood and the immune system: concerns and reality. , 2000, Haematologica.

[369]  M. Gasset,et al.  Methionine Sulfoxides on Prion Protein Helix-3 Switch on the α-Fold Destabilization Required for Conversion , 2009, PloS one.

[370]  M. Enari,et al.  Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[371]  H. Budka,et al.  The Original Gerstmann‐Sträussler‐Scheinker Family of Austria: Divergent Clinicopathological Phenotypes but Constant PrP Genotype , 1995, Brain pathology.

[372]  A. Aguzzi,et al.  A crucial role for B cells in neuroinvasive scrapie , 1997, Nature.

[373]  S. Prusiner,et al.  Molecular cloning of a candidate chicken prion protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[374]  J. de Figueiredo,et al.  Transmission studies from blood of Alzheimer disease patients and healthy relatives. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[375]  S. Haswell,et al.  Normal prion protein has an activity like that of superoxide dismutase. , 1999, The Biochemical journal.

[376]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[377]  A. Braunmühl.  Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems , 1954, Archiv für Psychiatrie und Nervenkrankheiten.

[378]  C. Weissmann.  Birth of a Prion: Spontaneous Generation Revisited , 2005, Cell.

[379]  P. Christen,et al.  Induction of antibodies against murine full-length prion protein in wild-type mice , 2002, Journal of Neuroimmunology.

[380]  E. Masliah,et al.  Prion-Induced Amyloid Heart Disease with High Blood Infectivity in Transgenic Mice , 2006, Science.

[381]  S. Itohara,et al.  Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. , 2003, Biochemical and biophysical research communications.

[382]  B. Volk,et al.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[383]  J. Heeney,et al.  The Immunophenotypic Characterization of Bovine Lymphomas , 1997, Veterinary pathology.

[384]  S. Prusiner,et al.  Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells , 1990, The Journal of cell biology.

[385]  F. Cohen,et al.  Recombinant scrapie-like prion protein of 106 amino acids is soluble. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[386]  A. Aguzzi,et al.  Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[387]  A. Kincaid,et al.  Extraneural Prion Neuroinvasion without Lymphoreticular System Infection , 2005, Journal of Virology.

[388]  B. Permanne,et al.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding , 2001, Nature.

[389]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[390]  N. Da.  Letter: Hepatitis with hindsight. , 1974 .

[391]  A. Kincaid,et al.  Rapid Prion Neuroinvasion following Tongue Infection , 2003, Journal of Virology.

[392]  S. Lindquist,et al.  Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol , 2002, Science.

[393]  S. Cousens,et al.  Geographical distribution of cases of Creutzfeldt-Jakob disease in England and Wales 1970-84. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[394]  A. Aguzzi,et al.  Chronic Lymphocytic Inflammation Specifies the Organ Tropism of Prions , 2005, Science.

[395]  Larry Simpson,et al.  A model for RNA editing in kinetoplastid mitochondria: RNA molecules transcribed from maxicircle DNA provide the edited information , 1990, Cell.

[396]  K. Doh-ura,et al.  Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease , 1991, Journal of virology.

[397]  S. Akira,et al.  Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration , 2004, Nature Medicine.

[398]  J Collinge,et al.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples , 1999, The Lancet.

[399]  H. Fraser,et al.  Pathogenesis of Scrapie in the Mouse: the Role of the Spleen , 1970, Nature.

[400]  Witold K. Surewicz,et al.  Crystal structure of the human prion protein reveals a mechanism for oligomerization , 2002, Nature Structural Biology.

[401]  D. Gajdusek,et al.  Possible modes of transmission of Creutzfeldt-Jakob disease. , 1984, The New England journal of medicine.

[402]  陶仲为.  Sarcoidosis , 2009 .

[403]  M. Lindgren,et al.  Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture. , 2008, Biochemical and biophysical research communications.

[404]  J. Platt,et al.  In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. , 1995, Science.

[405]  J. Miller,et al.  Abnormal Prion Protein in Ectopic Lymphoid Tissue in a Kidney of an Asymptomatic White-tailed Deer Experimentally Inoculated with the Agent of Chronic Wasting Disease , 2006, Veterinary pathology.

[406]  R. Kopito,et al.  Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates , 2009, Nature Cell Biology.

[407]  S. Prusiner,et al.  Immunoaffinity purification and neutralization of scrapie prion infectivity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[408]  S. Takemura.  Lymphoid neogenesis in rheumatoid synovitis , 2003 .

[409]  G. J. Raymond,et al.  Strain-dependent Differences in β-Sheet Conformations of Abnormal Prion Protein* , 1998, The Journal of Biological Chemistry.

[410]  M. D. Di Bari,et al.  Prion Protein Amino Acid Determinants of Differential Susceptibility and Molecular Feature of Prion Strains in Mice and Voles , 2008, PLoS pathogens.

[411]  J. Castilla,et al.  Presymptomatic Detection of Prions in Blood , 2006, Science.

[412]  D. Dormont,et al.  Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. , 2005, The American journal of pathology.

[413]  A. Bürkle,et al.  Overexpression of Nonconvertible PrPcΔ114–121 in Scrapie-Infected Mouse Neuroblastoma Cells Leads to trans-Dominant Inhibition of Wild-Type PrPSc Accumulation , 1998, Journal of Virology.

[414]  C. Donnelly,et al.  Transmission dynamics and epidemiology of BSE in British cattle , 1997, Nature.

[415]  M. Laue.  Electron microscopy of viruses. , 2010, Methods in cell biology.

[416]  T. Billette de Villemeur,et al.  Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus. , 1995, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[417]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[418]  E. Sigurdsson,et al.  Immunization delays the onset of prion disease in mice. , 2002, The American journal of pathology.

[419]  T. Kitamoto,et al.  Human prion diseases with variant prion protein. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[420]  S. Hall,et al.  Pathogenesis of mouse scrapie Evidence for direct neural spread of infection to the CNS after injection of sciatic nerve , 1983, Journal of the Neurological Sciences.

[421]  R. Casareno,et al.  Brain Copper Content and Cuproenzyme Activity Do Not Vary with Prion Protein Expression Level* , 2000, The Journal of Biological Chemistry.

[422]  A. Buschmann,et al.  Atypical scrapie cases in Germany and France are identified by discrepant reaction patterns in BSE rapid tests. , 2004, Journal of virological methods.

[423]  K. Nilsson,et al.  Synthesis of a regioregular zwitterionic conjugated oligoelectrolyte, usable as an optical probe for detection of amyloid fibril formation at acidic pH. , 2005, Journal of the American Chemical Society.

[424]  Shu G. Chen,et al.  Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.

[425]  B. Aronow,et al.  Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. , 2004, The EMBO journal.

[426]  R. S. Stewart,et al.  Mutant PrP Is Delayed in Its Exit from the Endoplasmic Reticulum, but Neither Wild-type nor Mutant PrP Undergoes Retrotranslocation Prior to Proteasomal Degradation* , 2003, Journal of Biological Chemistry.

[427]  E. Broussolle,et al.  New variant of Creutzfeldt-Jakob disease in a 26-year-old French man , 1996, The Lancet.

[428]  B. Ghetti,et al.  Neurological Illness in Transgenic Mice Expressing a Prion Protein with an Insertional Mutation , 1998, Neuron.

[429]  R. Will.  Epidemiology of Creutzfeldt-Jakob disease. , 1993, British medical bulletin.

[430]  Neil R. Cashman,et al.  Cellular isoform of the scrapie agent protein participates in lymphocyte activation , 1990, Cell.

[431]  C. Ware,et al.  The ligands and receptors of the lymphotoxin system. , 1995, Current topics in microbiology and immunology.

[432]  M. Sy,et al.  Expression and structural characterization of the recombinant human doppel protein. , 2000, Biochemistry.

[433]  J. Tew,et al.  Multiple lines of evidence favoring a bone marrow derivation of follicular dendritic cells (FDCs). , 1995, Advances in experimental medicine and biology.

[434]  F. Heppner,et al.  Transepithelial prion transport by M cells , 2001, Nature Medicine.

[435]  R. Marsh,et al.  Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy , 1994, Journal of virology.

[436]  S. Prusiner,et al.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein , 1992, Nature.

[437]  I. Cohen,et al.  Modulation of proteinase‐K resistant prion protein by prion peptide immunization , 2001, European journal of immunology.

[438]  F. Heppner,et al.  Disruption of Doppel prevents neurodegeneration in mice with extensive Prnp deletions , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[439]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[440]  A. Aguzzi,et al.  Prion research: the next frontiers , 1997, Nature.

[441]  A. Devoe,et al.  Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. , 1974, The New England journal of medicine.

[442]  A. Aguzzi,et al.  Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[443]  B. Caughey,et al.  Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[444]  M. Preece,et al.  Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. , 1991, BMJ.

[445]  Michele Vendruscolo,et al.  Role of Intermolecular Forces in Defining Material Properties of Protein Nanofibrils , 2007, Science.

[446]  Klaus Rajewsky,et al.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.

[447]  C. Soto.  Constraining the loop, releasing prion infectivity , 2009, Proceedings of the National Academy of Sciences.

[448]  B. Caughey,et al.  Potent Inhibition of Scrapie‐Associated PrP Accumulation by Congo Red , 1992, Journal of neurochemistry.

[449]  A. Aguzzi,et al.  Coincident Scrapie Infection and Nephritis Lead to Urinary Prion Excretion , 2005, Science.

[450]  A. McLean,et al.  The Potential Size and Duration of an Epidemic of Bovine Spongiform Encephalopathy in British Sheep , 2001, Science.

[451]  Ruedi Aebersold,et al.  A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.

[452]  Shu G. Chen,et al.  Protease-Resistant Human Prion Protein and Ferritin Are Cotransported across Caco-2 Epithelial Cells: Implications for Species Barrier in Prion Uptake from the Intestine , 2004, The Journal of Neuroscience.

[453]  I. Izquierdo,et al.  Physiology of the prion protein. , 2008, Physiological reviews.

[454]  J. Collinge,et al.  Strain-specific prion-protein conformation determined by metal ions , 1999, Nature Cell Biology.

[455]  S. Prusiner,et al.  Further purification and characterization of scrapie prions. , 1982, Biochemistry.

[456]  A. Campos-Neto,et al.  Chronic inflammation caused by lymphotoxin is lymphoid neogenesis , 1996, The Journal of experimental medicine.

[457]  I. Xenarios,et al.  Complement facilitates early prion pathogenesis , 2001, Nature Medicine.

[458]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[459]  J. Collinge,et al.  Transmission of Scrapie by Steel-surface-bound Prions , 2001, Molecular medicine.

[460]  S. Itohara,et al.  Prions prevent neuronal cell-line death , 1999, Nature.

[461]  G. C. Millson,et al.  Scrapie produced experimentally in goats with special reference to the clinical syndrome. , 1961, Journal of comparative pathology.

[462]  I. Mcconnell,et al.  129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal , 1994, Molecular Neurobiology.

[463]  J. Ironside,et al.  Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt–Jakob disease , 2000, Neuropathology and applied neurobiology.

[464]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[465]  Stanley B. Prusiner,et al.  Slow transmissible diseases of the nervous system , 1979 .

[466]  Patrick Couvreur,et al.  Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis , 2000, The Journal of pathology.

[467]  M. Shlomchik,et al.  Neuroinvasion by a Creutzfeldt–Jakob disease agent in the absence of B cells and follicular dendritic cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[468]  Jonathan S. Weissman,et al.  The physical basis of how prion conformations determine strain phenotypes , 2006, Nature.

[469]  M. Jeffrey,et al.  A novel progressive spongiform encephalopathy in cattle , 1987, Veterinary Record.

[470]  E. Kaiserling.  Newly-formed lymph nodes in the submucosa in chronic inflammatory bowel disease. , 2001, Lymphology.

[471]  Y. Goto,et al.  Seed-dependent accelerated fibrillation of alpha-synuclein induced by periodic ultrasonication treatment. , 2007, Journal of microbiology and biotechnology.

[472]  C. Hetz,et al.  Stressing out the ER: a role of the unfolded protein response in prion-related disorders. , 2006, Current molecular medicine.

[473]  A. Aguzzi,et al.  The prion's elusive reason for being. , 2008, Annual review of neuroscience.

[474]  M. Papa,et al.  Fibrillogenesis and Cytotoxic Activity of the Amyloid-forming Apomyoglobin Mutant W7FW14F* , 2004, Journal of Biological Chemistry.

[475]  Stanley B. Prusiner,et al.  Scrapie prion protein contains a phosphatidylinositol glycolipid , 1987, Cell.

[476]  TIKVAH ALPER,et al.  Does the Agent of Scrapie Replicate without Nucleic Acid ? , 1967, Nature.

[477]  Susan Lindquist,et al.  Prions as adaptive conduits of memory and inheritance , 2005, Nature Reviews Genetics.

[478]  R. Kimberlin,et al.  Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. , 1978, Journal of comparative pathology.

[479]  B. Chesebro,et al.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. , 2009, Annual review of biochemistry.

[480]  T. Crow,et al.  Codon 129 changes in the prion protein gene in Caucasians. , 1990, American journal of human genetics.

[481]  Ken Chen,et al.  Chronic Wasting Disease of Elk: Transmissibility to Humans Examined by Transgenic Mouse Models , 2005, The Journal of Neuroscience.

[482]  Michael W Miller,et al.  Patterns of PrPCWD accumulation during the course of chronic wasting disease infection in orally inoculated mule deer (Odocoileus hemionus). , 2006, The Journal of general virology.

[483]  A. Aguzzi,et al.  Novel dominant-negative prion protein mutants identified from a randomized library. , 2008, Protein engineering, design & selection : PEDS.

[484]  K. Rajewsky,et al.  Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. , 1996, Nature.

[485]  S. Prusiner,et al.  Prions and nucleic acids: search for "residual" nucleic acids and screening for mutations in the PrP-gene. , 1993, Developments in biological standardization.

[486]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[487]  C. V. Mering,et al.  Prion Protein Devoid of the Octapeptide Repeat Region Restores Susceptibility to Scrapie in PrP Knockout Mice , 2000, Neuron.

[488]  Sofia Nyström,et al.  Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[489]  C. Masters,et al.  Quinacrine does not prolong survival in a murine Creutzfeldt‐Jakob disease model , 2002, Annals of neurology.

[490]  S. Hornemann,et al.  The POM Monoclonals: A Comprehensive Set of Antibodies to Non-Overlapping Prion Protein Epitopes , 2008, PloS one.

[491]  B. Maddison,et al.  Use of thermolysin in the diagnosis of prion diseases , 2007, Molecular biotechnology.

[492]  D. Walsh,et al.  Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host , 2006, Science.

[493]  A. Aguzzi,et al.  Prion propagation in mice lacking central nervous system NF-kB signalling , 2008 .

[494]  J. Berger.  Kuru in the 21st century—an acquired human prion disease with very long incubation periods , 2008 .

[495]  S. Perrett,et al.  In Vitro Analysis of SpUre2p, a Prion-related Protein, Exemplifies the Relationship between Amyloid and Prion* , 2007, Journal of Biological Chemistry.

[496]  J. Laplanche,et al.  Deletion in prion protein gene in a Moroccan family. , 1990, Nucleic acids research.

[497]  R. Kimberlin,et al.  PATHOGENESIS OF MOUSE SCRAPIE: DYNAMICS OF VACUOLATION IN BRAIN AND SPINAL CORD AFTER INTRAPERITONEAL INFECTION , 1985, Neuropathology and applied neurobiology.

[498]  M. Beekes,et al.  Pathological PrP is abundant in sympathetic and sensory ganglia of hamsters fed with scrapie , 1999, Neuroscience Letters.

[499]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[500]  J. Hope,et al.  Atypical prion protein in sheep brain collected during the British scrapie-surveillance programme. , 2006, The Journal of general virology.

[501]  A. Aguzzi,et al.  Stromal Complement Receptor CD21/35 Facilitates Lymphoid Prion Colonization and Pathogenesis1 , 2007, The Journal of Immunology.

[502]  G. J. Raymond,et al.  The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. , 1991, The Journal of biological chemistry.

[503]  Michael W Miller,et al.  Human Prion Disease and Relative Risk Associated with Chronic Wasting Disease , 2006, Emerging infectious diseases.

[504]  L. Stoltze,et al.  A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[505]  S. Prusiner,et al.  Cholesterol Depletion and Modification of COOH-Terminal Targeting Sequence of the Priori Protein Inhibit Formation of the Scrapie Isoform , 2002 .

[506]  B. Caughey,et al.  Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein , 2007, Nature Methods.

[507]  S. Prusiner,et al.  Synthesis and trafficking of prion proteins in cultured cells. , 1992, Molecular biology of the cell.

[508]  A. Aguzzi,et al.  Bacterial colitis increases susceptibility to oral prion disease. , 2009, The Journal of infectious diseases.

[509]  M. Head,et al.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004, The Lancet.

[510]  S. Prusiner,et al.  Gel electrophoresis and glass permeation chromatography of the hamster scrapie agent after enzymatic digestion and detergent extraction. , 1980, Biochemistry.

[511]  Claudio J. Verzilli,et al.  Genetic risk factors for variant Creutzfeldt–Jakob disease: a genome-wide association study , 2009, The Lancet Neurology.

[512]  J. Laplanche,et al.  Different allelic effects of the codons 136 and 171 of the prion protein gene in sheep with natural scrapie. , 1995, The Journal of general virology.

[513]  S. Prusiner,et al.  Separation and properties of cellular and scrapie prion proteins. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[514]  J. Kraehenbuhl,et al.  Epithelial M Cells: Gateways for Mucosal Infection and Immunization , 1996, Cell.

[515]  A. Aguzzi,et al.  Truncated Prion Protein and Doppel Are Myelinotoxic in the Absence of Oligodendrocytic PrPC , 2005, The Journal of Neuroscience.

[516]  R. G. Anderson,et al.  Caveolae: where incoming and outgoing messengers meet. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[517]  K. Brown,et al.  Scrapie transmission following exposure through the skin is dependent on follicular dendritic cells in lymphoid tissues. , 2004, Journal of dermatological science.

[518]  Albert Taraboulos,et al.  Proteasomes and ubiquitin are involved in the turnover of the wild‐type prion protein , 2001, The EMBO journal.

[519]  P. Zampieri,et al.  Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. , 2003, The New England journal of medicine.

[520]  P. Brown,et al.  Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[521]  D. Harris,et al.  A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits , 1994, The Journal of cell biology.

[522]  P. Roller,et al.  Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity , 1993, Protein science : a publication of the Protein Society.

[523]  D. Healy,et al.  Creutzfeldt-Jakob disease after pituitary gonadotrophins. , 1993, BMJ.

[524]  R. Kisilevsky.  Preparation and propagation of amyloid-enhancing factor. , 2005, Methods in molecular biology.

[525]  A. Aguzzi,et al.  Mice devoid of PrP are resistant to scrapie , 1993, Cell.

[526]  D. Wysowski,et al.  Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. , 1991, JAMA.

[527]  Stephen J. DeArmond,et al.  Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques , 1989, Cell.

[528]  T. Noda,et al.  Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene , 1996, Nature.

[529]  A. Aguzzi.  Between cows and monkeys , 1996, Nature.

[530]  Andrew F. Hill,et al.  The same prion strain causes vCJD and BSE , 1997, Nature.

[531]  L. Hood,et al.  Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.

[532]  S. Cousens,et al.  Strain characterization of natural sheep scrapie and comparison with BSE. , 2002, The Journal of general virology.

[533]  S. Prusiner,et al.  A transmembrane form of the prion protein in neurodegenerative disease. , 1998, Science.

[534]  A. Li,et al.  Physiological expression of the gene for PrP-like protein, PrPLP/Dpl, by brain endothelial cells and its ectopic expression in neurons of PrP-deficient mice ataxic due to Purkinje cell degeneration. , 2000, The American journal of pathology.

[535]  A. Aguzzi,et al.  Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease , 2005, The Lancet Neurology.

[536]  S. Younkin,et al.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.

[537]  S. Lindquist,et al.  Hsp104 Catalyzes Formation and Elimination of Self-Replicating Sup35 Prion Conformers , 2004, Science.

[538]  G. Raposo,et al.  Retrovirus infection strongly enhances scrapie infectivity release in cell culture , 2006, The EMBO journal.

[539]  P. Costa,et al.  Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[540]  M. Palmer,et al.  Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein , 1995, Nature Genetics.

[541]  D. Chaplin,et al.  Distinct Roles of Lymphotoxin α and the Type I Tumor Necrosis Factor (TNF) Receptor in the Establishment of Follicular Dendritic Cells from Non–Bone Marrow–derived Cells , 1997, The Journal of experimental medicine.